Correlation Between Terns Pharmaceuticals and Solid Biosciences
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Solid Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Solid Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Solid Biosciences LLC, you can compare the effects of market volatilities on Terns Pharmaceuticals and Solid Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Solid Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Solid Biosciences.
Diversification Opportunities for Terns Pharmaceuticals and Solid Biosciences
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Terns and Solid is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Solid Biosciences LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Solid Biosciences LLC and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Solid Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Solid Biosciences LLC has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Solid Biosciences go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and Solid Biosciences
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to generate 0.97 times more return on investment than Solid Biosciences. However, Terns Pharmaceuticals is 1.03 times less risky than Solid Biosciences. It trades about -0.12 of its potential returns per unit of risk. Solid Biosciences LLC is currently generating about -0.21 per unit of risk. If you would invest 667.00 in Terns Pharmaceuticals on October 25, 2024 and sell it today you would lose (200.00) from holding Terns Pharmaceuticals or give up 29.99% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Terns Pharmaceuticals vs. Solid Biosciences LLC
Performance |
Timeline |
Terns Pharmaceuticals |
Solid Biosciences LLC |
Terns Pharmaceuticals and Solid Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Terns Pharmaceuticals and Solid Biosciences
The main advantage of trading using opposite Terns Pharmaceuticals and Solid Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Solid Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Solid Biosciences will offset losses from the drop in Solid Biosciences' long position.Terns Pharmaceuticals vs. X4 Pharmaceuticals | Terns Pharmaceuticals vs. Day One Biopharmaceuticals | Terns Pharmaceuticals vs. Hookipa Pharma | Terns Pharmaceuticals vs. Amylyx Pharmaceuticals |
Solid Biosciences vs. Century Therapeutics | Solid Biosciences vs. Edgewise Therapeutics | Solid Biosciences vs. C4 Therapeutics | Solid Biosciences vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |